As the field of psychedelic therapy continues to gain traction, it is becoming increasingly important for practitioners to ensure their treatments are safe and effective.
Depression can be treated in a number of ways. The traditional SSRI treatment is effective for some, but not for everyone. Studies on ketamine have shown that it is very helpful with depression, especially when other treatments have not been able to help as much.
The number of options for ketamine-assisted therapy is growing quickly, and you may be wondering how to choose the one that is right for you. Nushama happens to be quite different from most clinics—in fact, we don’t even call ourselves a “clinic,” and here are the reasons why.
Psychedelic integration is the process of drawing insight from an often enigmatic experience. It’s a practice of working with a professional to inform personal growth. The process of integration can even help make a “difficult” experience, a really valuable one.
Previous
Next
Nushama Blog
Ketamine has gained significant attention in recent years for its potential in treating depression, chronic pain, and other conditions. However, like any powerful medication, it's not suitable for everyone. Understanding the contraindications for ketamine use is crucial for patient safety and optimal treatment outcomes.
Ketamine has gained significant attention in recent years for its potential in treating depression, chronic pain, and other conditions. However, like any powerful medication, it's not suitable for everyone. Understanding the contraindications for ketamine use is crucial for patient safety and optimal treatment outcomes.
Ketamine's use as a depression treatment began in the early 2000s, after originally being used predominantly as a (very safe) anesthetic since its development in the 1960s. From the Yale study in 2000 to the FDA approval of ketamine, we review the last 20 years of growth.
The transformative power of ketamine doesn't end when the infusion stops - when it does stop, you’ve got an approximate 2-3 day window of high neural plasticity, and a window to create true, lasting change - this is where integration steps in.
Research and case studies covering ketamine's efficacy in treating chronic pain conditions like fibromyalgia and CRPS (Complex Regional Pain Syndrome).
30 days of journal prompts to support introspection - whether preparing for, or integrating, a transformative psychedelic journey, or simply seeking to understand yourself better, these 30 journal prompts can guide you toward deeper self-awareness and personal development.
We review the current status of ketamine as a Schedule III drug, its DEA regulation and FDA classification, and their impact on applications, research, and insurance coverage.
Reflecting on the tragic loss of Matthew Perry, we discuss the critical importance of safe, ethical ketamine use. Explore our safety protocols and our response to the misuse highlighted by recent events.
Synthesized by Calvin Stevens, pushed through clinical trials by Domino and Corssen, and researched by more and more scientific and medical pioners: we explore prominent figures in ketamine’s development in the last 50+ years.
“Ketamine bladder" or "ketamine cystitis” is recognized by symptoms such as frequent urination, urgency, pain, and even bladder inflammation. Note: these problems are primarily linked to recreational use, where individuals consume ketamine in unregulated and excessive amounts.
